Developing ModRUM: a standardised, generic, modular resource-use measure
Dr Joanna Thorn, Associate Professor in Health Economics and Head of Health Economics and Health Policy at Bristol and Dr Kirsty Garfield, Senior Research Fellow in Health Economic Evaluation at HEHP@Bristol and the Bristol Trials Centre
Thursday, 16 October 2025, 1pm to 2pm
Date and time: Thursday 16 October, 13:00 hours
Location: L1 Main Meeting Room, Richard Doll Building, Old Road Campus, Headington, OX3 7LF
To Join: This is a free event, which will be taking place both in-person and online via Zoom/Microsoft Teams. Register
Abstract:
Despite the importance of the 'cost' part of cost-effectiveness, resource-use measurement in empirical studies has had a chequered history. Typically, health economists will collect data from patients via questionnaires which are rarely tested and of unknown validity. In this seminar, we will provide an overview of the development of ModRUM (bristol.ac.uk/modrum). ModRUM was designed to increase standardisation whilst being flexible to allow for relevant data to be collected in a wide range of studies. Development incorporated iterative testing, stakeholder engagement and validation studies to ensure usability and relevance. ModRUM includes healthcare, social care, informal care and aids/adaptations modules. Ongoing work includes the development of an electronic version. This seminar will be of interest to researchers involved in trial design, health economics, and health services research.
Bio:
Dr Joanna Thorn is an Associate Professor in Health Economics and Head of Health Economics and Health Policy at Bristol (HEHP@Bristol). Her research interests encompass methodological aspects of costing health and social care, as well as applied economic evaluations conducted alongside RCTs and other study designs.
Dr Kirsty Garfield is a Senior Research Fellow in Health Economic Evaluation at HEHP@Bristol and the Bristol Trials Centre. She has experience of conducting applied economic evaluations alongside a wide range of randomised controlled trials, and a keen interest in trials methodology research.